Homopeptide timeline
Every Homopeptide batch the index holds, newest manufacture date first, with the supplier's declared purity beside the median of the index's independent observations of the same lot.
| Lot | Compound | Manufactured | Quarter | Tests | Independent median | Spread (pp) | COA purity | Divergence (pp) | |
|---|---|---|---|---|---|---|---|---|---|
| HOMO-2608-A3930 | Ipamorelin | 27 Aug 2026 | 2026-Q3 | 2 | 99.47 | 0.47 | 99.47 | 0.00 | |
| HOMO-2607-P5131 | IGF-1 LR3 | 10 Jul 2026 | 2026-Q3 | 14 | 98.93 | 0.88 | 98.97 | +0.04 | |
| HOMO-2605-S5227 | Semax | 26 May 2026 | 2026-Q3 | 11 | 99.93 | 0.34 | 99.90 | -0.03 | |
| HOMO-2605-V4718 | Retatrutide | 02 May 2026 | 2026-Q3 | 5 | 98.68 | 0.64 | 98.54 | -0.14 | |
| HOMO-2604-D5484 | SS-31 (Elamipretide) | 29 Apr 2026 | 2026-Q3 | 7 | 99.93 | 0.18 | 99.90 | -0.03 | |
| HOMO-2604-X3806 | Semaglutide | 11 Apr 2026 | 2026-Q3 | 3 | 99.04 | 0.32 | 98.75 | -0.29 | |
| HOMO-2603-C5267 | N-Acetyl Semax Amide | 27 Mar 2026 | 2026-Q2 | 12 | 99.12 | 0.66 | 98.74 | -0.38 | |
| HOMO-2602-S3200 | Semax | 24 Feb 2026 | 2026-Q1 | 11 | 99.66 | 0.42 | 99.05 | -0.61 | |
| HOMO-2602-V3961 | Glucagon | 20 Feb 2026 | 2026-Q2 | 12 | 99.22 | 0.73 | 99.31 | +0.09 | |
| HOMO-2602-E3918 | GHRP-2 | 14 Feb 2026 | 2026-Q2 | 1 | 99.93 | n<2 | 99.50 | -0.43 | |
| HOMO-2602-G5165 | LL-37 | 09 Feb 2026 | 2026-Q3 | 3 | 99.01 | 0.43 | 98.94 | -0.07 | |
| HOMO-2602-K4395 | ARA-290 | 07 Feb 2026 | 2026-Q1 | 9 | 99.42 | 0.73 | 99.67 | +0.25 | |
| HOMO-2602-R3080 | Hexarelin | 06 Feb 2026 | 2026-Q2 | 3 | 99.66 | 0.21 | 99.79 | +0.13 | |
| HOMO-2601-N4081 | Tirzepatide | 29 Jan 2026 | 2026-Q2 | 8 | 98.95 | 1.41 | 99.62 | +0.67 | |
| HOMO-2601-J3763 | Retatrutide | 19 Jan 2026 | 2026-Q1 | 16 | 99.04 | 0.59 | 99.32 | +0.28 | |
| HOMO-2601-T3123 | ARA-290 | 16 Jan 2026 | 2026-Q2 | 9 | 99.70 | 0.53 | 99.65 | -0.05 | |
| HOMO-2601-D3090 | Semax | 09 Jan 2026 | 2026-Q1 | 7 | 98.90 | 0.94 | 98.98 | +0.08 | SHARED BULK |
| HOMO-2512-Y5409 | Semax | 29 Dec 2025 | 2026-Q1 | 1 | 99.60 | n<2 | 99.54 | -0.06 | |
| HOMO-2512-D4932 | Retatrutide | 22 Dec 2025 | 2026-Q2 | 4 | 98.78 | 0.91 | 99.50 | +0.72 | |
| HOMO-2512-A5108 | Epitalon | 22 Dec 2025 | 2026-Q2 | 10 | 99.93 | 0.54 | 99.41 | -0.52 | |
| HOMO-2512-D5035 | CJC-1295 (no DAC) | 08 Dec 2025 | 2026-Q1 | 1 | 99.69 | n<2 | 99.57 | -0.12 | |
| HOMO-2512-V4503 | PT-141 (Bremelanotide) | 01 Dec 2025 | 2026-Q1 | 1 | 99.93 | n<2 | 99.90 | -0.03 | |
| HOMO-2511-V4580 | Afamelanotide | 25 Nov 2025 | 2026-Q1 | 1 | 99.38 | n<2 | 99.82 | +0.44 | |
| HOMO-2511-M5084 | Melanotan II | 14 Nov 2025 | 2026-Q1 | 1 | 99.42 | n<2 | 98.99 | -0.43 | |
| HOMO-2511-G4082 | Semaglutide | 11 Nov 2025 | 2025-Q4 | 1 | 99.40 | n<2 | 99.85 | +0.45 | |
| HOMO-2511-C4492 | Semaglutide | 01 Nov 2025 | 2026-Q1 | 15 | 99.17 | 0.89 | 98.86 | -0.31 | |
| HOMO-2510-E3541 | Tirzepatide | 10 Oct 2025 | 2025-Q4 | 8 | 98.51 | 1.16 | 98.95 | +0.44 | |
| HOMO-2509-X4966 | Leuprolide | 30 Sep 2025 | 2025-Q4 | 1 | 99.11 | n<2 | 99.62 | +0.51 | |
| HOMO-2509-F5826 | Semaglutide | 27 Sep 2025 | 2025-Q4 | 11 | 99.57 | 0.83 | 99.90 | +0.33 | |
| HOMO-2509-K4706 | Afamelanotide | 06 Sep 2025 | 2026-Q1 | 1 | 99.21 | n<2 | 99.50 | +0.29 | |
| HOMO-2508-N3727 | Leuprolide | 23 Aug 2025 | 2026-Q1 | 10 | 99.64 | 0.73 | 99.19 | -0.45 | |
| HOMO-2508-Y3248 | Retatrutide | 03 Aug 2025 | 2025-Q4 | 4 | 98.29 | 0.56 | 97.89 | -0.40 | |
| HOMO-2508-U3892 | Retatrutide | 02 Aug 2025 | 2025-Q3 | 12 | 98.69 | 1.27 | 98.89 | +0.20 | |
| HOMO-2507-D3703 | Selank | 04 Jul 2025 | 2025-Q3 | 4 | 99.73 | 0.18 | 99.83 | +0.10 | |
| HOMO-2506-M5731 | Semaglutide | 27 Jun 2025 | 2025-Q3 | 15 | 97.85 | 0.86 | 98.08 | +0.23 | SHARED BULK |
| HOMO-2506-V3648 | Semaglutide | 16 Jun 2025 | 2025-Q3 | 2 | 98.74 | 0.65 | 98.50 | -0.24 | |
| HOMO-2506-L4686 | MK-677 (Ibutamoren mesylate) | 07 Jun 2025 | 2025-Q4 | 13 | 99.93 | 0.42 | 99.90 | -0.03 | |
| HOMO-2505-T3389 | GHRP-2 | 17 May 2025 | 2025-Q4 | 1 | 99.59 | n<2 | 99.90 | +0.31 | |
| HOMO-2505-N4086 | Melanotan II | 16 May 2025 | 2025-Q4 | 4 | 98.95 | 0.53 | 99.80 | +0.85 | |
| HOMO-2505-V3835 | Semaglutide | 05 May 2025 | 2025-Q3 | 14 | 98.55 | 1.34 | 99.37 | +0.82 | |
| HOMO-2504-G4514 | GHRP-6 | 19 Apr 2025 | 2025-Q2 | 3 | 99.79 | 0.23 | 99.90 | +0.11 | |
| HOMO-2502-U4118 | Tirzepatide | 27 Feb 2025 | 2025-Q2 | 5 | 98.33 | 0.48 | 98.46 | +0.13 | |
| HOMO-2502-H4892 | Melanotan II | 23 Feb 2025 | 2025-Q1 | 1 | 99.93 | n<2 | 99.80 | -0.13 | |
| HOMO-2501-D4523 | Semaglutide | 14 Jan 2025 | 2025-Q1 | 7 | 99.45 | 0.20 | 99.90 | +0.45 | |
| HOMO-2501-D4371 | L-Glutathione (reduced) | 09 Jan 2025 | 2025-Q1 | 11 | 99.84 | 0.64 | 99.37 | -0.47 | |
| HOMO-2501-A5192 | Semaglutide | 05 Jan 2025 | 2025-Q2 | 7 | 99.76 | 0.41 | 99.90 | +0.14 | |
| HOMO-2412-B4014 | PEG-MGF | 19 Dec 2024 | 2025-Q2 | 1 | 98.10 | n<2 | 98.32 | +0.22 | |
| HOMO-2411-P5026 | KPV | 25 Nov 2024 | 2025-Q1 | 13 | 99.48 | 1.05 | 99.56 | +0.08 | |
| HOMO-2411-S5371 | N-Acetyl Semax Amide | 18 Nov 2024 | 2024-Q4 | 4 | 99.83 | 0.28 | 99.75 | -0.08 | |
| HOMO-2411-K4425 | BPC-157 | 03 Nov 2024 | 2025-Q1 | 2 | 99.90 | 0.04 | 99.83 | -0.07 | |
| HOMO-2410-E3347 | TB-500 | 23 Oct 2024 | 2025-Q1 | 2 | 99.64 | 0.59 | 99.89 | +0.25 | |
| HOMO-2410-K5866 | SS-31 (Elamipretide) | 15 Oct 2024 | 2024-Q4 | 10 | 99.91 | 0.44 | 99.90 | -0.01 | |
| HOMO-2409-R4202 | Retatrutide | 05 Sep 2024 | 2025-Q1 | 3 | 99.37 | 0.71 | 99.32 | -0.05 | |
| HOMO-2408-C3445 | GHK-Cu | 30 Aug 2024 | 2024-Q3 | 13 | 99.10 | 0.92 | 98.60 | -0.50 | |
| HOMO-2408-G5365 | BPC-157 | 27 Aug 2024 | 2024-Q3 | 3 | 99.16 | 0.36 | 98.94 | -0.22 | |
| HOMO-2408-P4132 | PT-141 (Bremelanotide) | 16 Aug 2024 | 2024-Q4 | 1 | 99.93 | n<2 | 99.79 | -0.14 | |
| HOMO-2408-A5115 | Humanin (HNG) | 12 Aug 2024 | 2025-Q1 | 1 | 99.58 | n<2 | 99.74 | +0.16 | |
| HOMO-2408-R3237 | L-Glutathione (reduced) | 06 Aug 2024 | 2025-Q1 | 4 | 99.01 | 0.55 | 99.45 | +0.44 | SHARED BULK |
| HOMO-2407-T4218 | GHRP-6 | 20 Jul 2024 | 2024-Q3 | 8 | 99.90 | 0.39 | 99.79 | -0.11 | |
| HOMO-2406-F5091 | Survodutide | 18 Jun 2024 | 2024-Q4 | 14 | 99.35 | 0.92 | 99.52 | +0.17 | |
| HOMO-2406-T4667 | Retatrutide | 13 Jun 2024 | 2024-Q3 | 3 | 98.18 | 0.69 | 98.05 | -0.13 | |
| HOMO-2405-U3389 | Oxytocin | 28 May 2024 | 2024-Q3 | 14 | 99.93 | 0.30 | 99.73 | -0.20 | |
| HOMO-2405-T3880 | BPC-157 | 22 May 2024 | 2024-Q3 | 1 | 99.02 | n<2 | 98.92 | -0.10 | |
| HOMO-2405-P5405 | L-Carnosine | 20 May 2024 | 2024-Q2 | 6 | 99.66 | 0.63 | 99.90 | +0.24 | |
| HOMO-2405-B3923 | Retatrutide | 18 May 2024 | 2024-Q3 | 6 | 98.00 | 0.51 | 98.29 | +0.29 | |
| HOMO-2401-X5365 | N-Acetyl Semax Amide | 17 Jan 2024 | 2024-Q1 | 1 | 99.63 | n<2 | 99.35 | -0.28 | |
| HOMO-2401-J3421 | MK-677 (Ibutamoren mesylate) | 17 Jan 2024 | 2024-Q2 | 6 | 99.85 | 0.66 | 99.90 | +0.05 | |
| HOMO-2401-R3356 | Semaglutide | 07 Jan 2024 | 2024-Q2 | 11 | 98.81 | 0.83 | 98.85 | +0.04 | |
| HOMO-2311-M4446 | Semaglutide | 22 Nov 2023 | 2024-Q2 | 4 | 98.50 | 0.11 | 98.50 | 0.00 | |
| HOMO-2311-R5976 | Retatrutide | 17 Nov 2023 | 2024-Q2 | 11 | 98.14 | 0.90 | 98.37 | +0.23 | |
| HOMO-2308-R3867 | TB-500 | 10 Aug 2023 | 2024-Q1 | 13 | 99.43 | 0.49 | 99.36 | -0.07 |